Najmeh Moradi

669 total citations
52 papers, 387 citations indexed

About

Najmeh Moradi is a scholar working on Economics and Econometrics, Oncology and General Health Professions. According to data from OpenAlex, Najmeh Moradi has authored 52 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Economics and Econometrics, 9 papers in Oncology and 8 papers in General Health Professions. Recurrent topics in Najmeh Moradi's work include Health Systems, Economic Evaluations, Quality of Life (20 papers), Pharmaceutical Economics and Policy (10 papers) and Economic and Environmental Valuation (8 papers). Najmeh Moradi is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (20 papers), Pharmaceutical Economics and Policy (10 papers) and Economic and Environmental Valuation (8 papers). Najmeh Moradi collaborates with scholars based in Iran, United Kingdom and Belgium. Najmeh Moradi's co-authors include Leila Zarei, Kamran Bagheri Lankarani, Seyed Taghi Heydari, Gholamhossein Mehralian, Ahmad Kalateh Sadati, Maryam Akbari, Arash Rashidian, Alireza Olyaeemanesh, Mohammad Zibaei and Saeed Bahadory and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Lancet Infectious Diseases and International Journal of Environmental Research and Public Health.

In The Last Decade

Najmeh Moradi

48 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Najmeh Moradi Iran 11 113 77 62 56 35 52 387
Diep Ngoc Nguyen Vietnam 10 43 0.4× 50 0.6× 51 0.8× 35 0.6× 17 0.5× 17 305
Shokrollah Mohseni Iran 10 53 0.5× 42 0.5× 61 1.0× 47 0.8× 39 1.1× 52 408
Katarzyna Naylor Poland 7 67 0.6× 69 0.9× 50 0.8× 17 0.3× 59 1.7× 29 457
Wairagala Wakabi Sweden 10 35 0.3× 117 1.5× 61 1.0× 47 0.8× 29 0.8× 58 388
Thomas A. Burke United States 6 33 0.3× 64 0.8× 26 0.4× 37 0.7× 55 1.6× 8 416
Lakshmi Krishnan United States 7 78 0.7× 33 0.4× 39 0.6× 117 2.1× 49 1.4× 20 426
Jeffrey Glenn United States 11 24 0.2× 68 0.9× 24 0.4× 28 0.5× 36 1.0× 25 423
Jimoh Amzat Nigeria 9 59 0.5× 47 0.6× 52 0.8× 55 1.0× 21 0.6× 58 322
David Walton United States 8 30 0.3× 57 0.7× 35 0.6× 90 1.6× 35 1.0× 13 307
Mark Gallivan United States 7 69 0.6× 39 0.5× 39 0.6× 118 2.1× 62 1.8× 14 339

Countries citing papers authored by Najmeh Moradi

Since Specialization
Citations

This map shows the geographic impact of Najmeh Moradi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Najmeh Moradi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Najmeh Moradi more than expected).

Fields of papers citing papers by Najmeh Moradi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Najmeh Moradi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Najmeh Moradi. The network helps show where Najmeh Moradi may publish in the future.

Co-authorship network of co-authors of Najmeh Moradi

This figure shows the co-authorship network connecting the top 25 collaborators of Najmeh Moradi. A scholar is included among the top collaborators of Najmeh Moradi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Najmeh Moradi. Najmeh Moradi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moradi, Najmeh, et al.. (2025). Women's Intention to Participate in Predictive Breast Cancer Genetic Testing: A Cross‐Sectional Survey of in Iran. Health Science Reports. 8(7). e70985–e70985. 1 indexed citations
2.
Moradi, Najmeh, et al.. (2024). Public Preference for Financing Preventive Vaccines in Health Shocks: The Case of COVID-19 Vaccines in a Middle-Income Country. PharmacoEconomics - Open. 8(4). 559–568. 1 indexed citations
3.
Rice, Stephen, Hosein Shabaninejad, Fiona Pearson, et al.. (2023). Economic evaluations of interventions to prevent and control health-care-associated infections: a systematic review. The Lancet Infectious Diseases. 23(7). e228–e239. 15 indexed citations
4.
Ghahramani, Sulmaz, et al.. (2022). Estimating willingness to pay for diabetes complications. Primary care diabetes. 16(6). 829–836.
5.
Rezapour, Aziz, et al.. (2022). Women’s Preference for Cervical Cancer Screening Methods in Iran: A Contingent Valuation Survey. Medical Journal of the Islamic Republic of Iran. 36. 72–72.
6.
Rezapour, Aziz, et al.. (2022). Safety and Effectiveness of Endodermal Radiofrequency for Skin Rejuvenation: A Systematic Review. Aesthetic Plastic Surgery. 47(1). 378–386. 2 indexed citations
7.
Rezapour, Aziz, Vahid Alipour, Najmeh Moradi, & Jalal Arabloo. (2022). Cost-Effectiveness of Multiparametric Magnetic Resonance Imaging and Targeted Biopsy Versus Systematic Transrectal Ultrasound-Guided Biopsy for Prostate Cancer Diagnosis: A Systematic Review. Value in Health Regional Issues. 30. 31–38. 3 indexed citations
8.
Ghahramani, Sulmaz, et al.. (2022). Preserving natural teeth versus extracting them: a willingness to pay analysis. BMC Oral Health. 22(1). 375–375. 4 indexed citations
9.
Moradi, Najmeh, et al.. (2021). Population or family history based BRCA gene tests of breast cancer? A systematic review of economic evaluations. Hereditary Cancer in Clinical Practice. 19(1). 35–35. 11 indexed citations
10.
Moradi, Najmeh, et al.. (2021). Medication Cost of Enzyme Replacement Therapy for Mucopolysaccharidoses in Iran. SHILAP Revista de lepidopterología. 1 indexed citations
11.
Rezapour, Aziz, et al.. (2021). Willingness to pay for and acceptance of cervical cancer prevention methods: A systematic review and meta-analysis. Medical Journal of the Islamic Republic of Iran. 35. 81–81. 3 indexed citations
12.
Bastani, Peivand, et al.. (2021). Students and teachers᾽ Attitudes Toward counsultor Planning and Identify Problems and solutions. Research in Medical Education. 13(4). 35–44. 1 indexed citations
13.
Rezapour, Aziz, et al.. (2020). Men’s willingness to pay for prostate cancer screening: a systematic review. Systematic Reviews. 9(1). 290–290. 5 indexed citations
14.
Khosravi, Mohammad, et al.. (2020). Evaluation of a rapid enzyme immunoassay test for diagnosis of contamination of milk, water and feces to Salmonella Typhimurium. Veterinarski arhiv. 90(5). 509–516. 2 indexed citations
15.
Moradi, Najmeh, et al.. (2019). Willingness to pay for one quality-adjusted life year in Iran. Cost Effectiveness and Resource Allocation. 17(1). 4–4. 15 indexed citations
16.
Rashidian, Arash, et al.. (2018). Health State Utilities for Patient's Current Health from Bipolar Type I Disorder.. PubMed. 21(1). 3–10. 2 indexed citations
17.
Moradi, Najmeh, et al.. (2016). Economic Evaluation of Infliximab for Treatment of Refractory Ulcerative Colitis in Iran: Cost-Effectiveness Analysis. Iranian journal of pharmaceutical sciences. 12(4). 33–42. 2 indexed citations
18.
Moradi, Najmeh, et al.. (2015). Willingness to Pay for One Quality Adjusted Life Years In Patients With Diabetes. Value in Health. 18(7). A616–A617. 6 indexed citations
19.
Moradi, Najmeh, et al.. (2015). Economic Evaluation of Infliximab for Treatment of Refractory Ulcerative Colitis In Iran: Cost-Effectiveness Analysis. Value in Health. 18(7). A628–A628. 2 indexed citations
20.
Moradi, Najmeh, et al.. (2015). First report of Sugarcane streak mosaic virus in Iran. New Disease Reports. 32(1). 2–2. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026